A clearer reading

Effects of cannabidiol on simulated driving and cognitive performance: A dose-ranging randomised controlled trial

Study preparation, population, findings and limitations with original source links.

Content reviewed 2026-10-25 · Local preview

Back to all research · More in Cognition and driving

Human2022-05-30

Cognition and driving · CBD

Journal of psychopharmacology (Oxford, England) · PMID 35637624

Randomized double-blind crossover trial

Studied preparation
Oral CBD preparations compared with placebo in separate acute sessions.
Population / model
17 healthy adults studied in controlled simulated-driving sessions.
What was observed
Several simulator comparisons met the study’s non-inferiority criterion; others were inconclusive.
Interpretation limit

Small acute simulator study; this is not permission to drive after using CBD, THC-containing products or combinations.

Online publication · Source checked 2026-10-25

Sources, registration and terms

Citation and publication date recorded; peer-review/preprint status not separately classified.

PMC full-text link is recorded; current access and reuse rights are not verified here.

Registry state is a dated sponsor report; it does not confirm current recruitment or establish benefit.

  • Recorded registration ID; registry status/results not checked in this library
    Original ACTRN12619001552178
    Registry-posted results: not recorded

CBD / cannabidiol · Human study · Registered trial · Primary versus secondary outcome

Package comparison guides; not clinical equivalence

Suggest a source correction

Copy a note and share it with the person who sent this preview. This page does not send or store your note.

Nothing has been sent.